Gharaee-Kermani M, Denholm E M, Phan S H
Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0602, USA.
J Biol Chem. 1996 Jul 26;271(30):17779-84. doi: 10.1074/jbc.271.30.17779.
Recent studies indicate potential roles of monocyte chemotactic protein-1 (MCP-1) in recruitment of monocytes to sites of inflammation. However, their increased expression does not always correlate with monocyte influx, suggesting other possible biological activities for this member of the C-C chemokine family. In view of its potential role in regulating extracellular matrix expression in fibrotic disorders, the effects of MCP-1 on lung fibroblast collagen expression were evaluated. Isolated rat lung fibroblasts were treated with increasing doses of MCP-1 for variable periods of time and examined for effects on collagen synthesis and expression of procollagen alpha1(I) mRNA expression. The results show that MCP-1 was able to stimulate collagen expression in these cells in a dose-dependent manner but required over 24 h for significant elevation to occur. In view of this delayed time course, the possibility of mediation via endogenous transforming growth factor beta (TGFbeta) was tested by the ability of anti-TGFbeta antibody to inhibit this MCP-1 stimulation of collagen expression. Significant but incomplete inhibition by this antibody was observed. Pretreatment of the cells with antisense but not by sense or missense TGFbeta1 oligodeoxyribonucleotides caused essentially complete inhibition of this MCP-1 stimulatory effect. Furthermore, MCP-1 treatment was found to also stimulate TGFbeta secretion and mRNA expression, which was also abolished by pretreatment with antisense TGFbeta1 oligodeoxyribonucleotides. The kinetics of TGFbeta expression indicates that significant increase preceded that for collagen expression. Binding studies using 125I-labeled MCP-1 indicated the presence of specific and saturable binding sites with a dissociation constant consistent with the dose response curves for stimulation of fibroblast collagen synthesis and TGFbeta activity by MCP-1. These results taken together suggest that MCP-1 stimulates fibroblast collagen expression via specific receptors and endogenous up-regulation of TGFbeta expression. The latter then results in autocrine and/or juxtacrine stimulation of collagen gene expression.
近期研究表明,单核细胞趋化蛋白-1(MCP-1)在将单核细胞募集到炎症部位方面具有潜在作用。然而,其表达增加并不总是与单核细胞流入相关,这表明C-C趋化因子家族的这一成员可能还具有其他生物学活性。鉴于其在调节纤维化疾病中细胞外基质表达方面的潜在作用,对MCP-1对肺成纤维细胞胶原蛋白表达的影响进行了评估。用递增剂量的MCP-1处理分离的大鼠肺成纤维细胞不同时间,并检测其对胶原蛋白合成和前胶原α1(I)mRNA表达的影响。结果表明,MCP-1能够以剂量依赖的方式刺激这些细胞中的胶原蛋白表达,但需要超过24小时才能出现显著升高。鉴于这种延迟的时间进程,通过抗转化生长因子β(TGFβ)抗体抑制MCP-1对胶原蛋白表达的刺激能力,来测试内源性TGFβ介导的可能性。观察到该抗体有显著但不完全的抑制作用。用反义而非正义或错义TGFβ1寡脱氧核糖核苷酸预处理细胞,可基本完全抑制这种MCP-1的刺激作用。此外,发现MCP-1处理还能刺激TGFβ分泌和mRNA表达,用反义TGFβ1寡脱氧核糖核苷酸预处理也可消除这种作用。TGFβ表达的动力学表明,其显著增加先于胶原蛋白表达。使用125I标记的MCP-1进行的结合研究表明存在特异性和可饱和的结合位点,其解离常数与MCP-1刺激成纤维细胞胶原蛋白合成和TGFβ活性的剂量反应曲线一致。综合这些结果表明,MCP-1通过特异性受体和TGFβ表达的内源性上调来刺激成纤维细胞胶原蛋白表达。后者进而导致胶原蛋白基因表达的自分泌和/或旁分泌刺激。